Reil, P.M.; Maghiar, T.T.; Vîlceanu, N.; Pascalau, A.; Judea Pusta, C.T.; Marcu, F.; Cavalu, S.; Pop, O.
Assessing the Role of Lipopolysaccharide (LPS) Receptor (CD14) in Septic Cardiomyopathy: The Value of Immunohistochemical Diagnostics. Diagnostics 2022, 12, 781.
https://doi.org/10.3390/diagnostics12040781
AMA Style
Reil PM, Maghiar TT, Vîlceanu N, Pascalau A, Judea Pusta CT, Marcu F, Cavalu S, Pop O.
Assessing the Role of Lipopolysaccharide (LPS) Receptor (CD14) in Septic Cardiomyopathy: The Value of Immunohistochemical Diagnostics. Diagnostics. 2022; 12(4):781.
https://doi.org/10.3390/diagnostics12040781
Chicago/Turabian Style
Reil, Peter Michael, Teodor Traian Maghiar, Narcis Vîlceanu, Andrei Pascalau, Claudia Teodora Judea Pusta, Florin Marcu, Simona Cavalu, and Ovidiu Pop.
2022. "Assessing the Role of Lipopolysaccharide (LPS) Receptor (CD14) in Septic Cardiomyopathy: The Value of Immunohistochemical Diagnostics" Diagnostics 12, no. 4: 781.
https://doi.org/10.3390/diagnostics12040781
APA Style
Reil, P. M., Maghiar, T. T., Vîlceanu, N., Pascalau, A., Judea Pusta, C. T., Marcu, F., Cavalu, S., & Pop, O.
(2022). Assessing the Role of Lipopolysaccharide (LPS) Receptor (CD14) in Septic Cardiomyopathy: The Value of Immunohistochemical Diagnostics. Diagnostics, 12(4), 781.
https://doi.org/10.3390/diagnostics12040781
